NCT02142400View on ClinicalTrials.gov

Multiple Ascending Dose Study of DS-1093 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

31

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions

Anaemia

Interventions

DRUG

DS-1093

DS-1093 in capsules with 2.5mg or 25mg per capsule

DRUG

placebo

matching placebo capsules to DS-1093 capsules

Trial Locations (1)

Unknown

Hammersmith Medicines Research Ltd, London

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Daiichi Sankyo

INDUSTRY